A competitive study between mukhadushikahar lepa and gel and its clinical, analytical and pharmaceutical study

A pharmaceutico analytical and comparitive clinical study of mukhadushikahar lepa and mukhadushikahar gel in the management of mukhadushika

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/016856

Enrollment

Registered

2019-01-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Mukhdushikahar lep: fine powder of Dhanyak(Coriandrum sativum) Darvi(Barbaris aristata) Tulsi(ocimum Sanctum) Shalmali(Salmalia Malberica) Bakuchi(Psoralia coryfloria) Yeshtimadhu(Glyco

Eligibility

Inclusion criteria

Inclusion criteria: 60 patients of age group 15 to 30 ears with pimples irrespective of gender religion occupation and who are willing to give inform written consent will be included in the study

Exclusion criteria

Exclusion criteria: hyper pigmentation due to any other reason Patient with severe skin infection Other skin disease Hyper sensitivity t cosmetics Diagnosed severe systemic disease

Design outcomes

Primary

Measure	Time frame
No of Mukhadushika on face at starting day of study.Timepoint: No of Mukhadushika on 15 th day of study and after 1 month of study	—

Secondary

Measure	Time frame
Discoloration 1.Discolouration of skin involved 2.strav from lesion 3.itching at face 4.pain in lesion 5.burning in lesion Timepoint: Scores will be given to each outcome as 0 to 3	—

Countries

India

Contacts

Public Contactshweta helge

CARC

manerajendra8@gmail.com09422422474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026